novo nordisk glp-1 medications launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry Novo Nordisk, Hims & Hers
Description
A prespecified analysis of the FLOW trial evaluated the composite time to the first occurrence of heart failure events (including new onset or worsening heart failure that resulted in an unscheduled hospital admission or urgent visit) or CV death

As lifestyle changes, including poor dietary habits and decreased physical activity, lead to higher rates of these conditions, the demand for effective treatment options has glucagon-like peptide 1 (GLP-1) analogues

You dont have to figure this out alone

The program, currently available in 28 states, is intended for eligible overweight and obese adults ages 18-64 who plan to self-pay for their GLP-1 medication
Do GLP-1 microneedles work
